1. Home
  2. LYNX vs DMRA Comparison

LYNX vs DMRA Comparison

Compare LYNX & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyntris Inc. Common Stock

LYNX

Lyntris Inc. Common Stock

N/A

Current Price

$11.42

Market Cap

1.6B

Sector

Industrials

ML Signal

N/A

DMRA

Damora Therapeutics Inc. Common Stock

SELL

Current Price

$19.97

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LYNX
DMRA
Founded
2018
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
LYNX
DMRA
Price
$11.42
$19.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
10
Target Price
$19.67
★ $46.89
AVG Volume (30 Days)
459.1K
★ 739.6K
Earning Date
11-20-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 121.48
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.28
N/A
Revenue Next Year
$34.08
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.20
$16.50
52 Week High
$14.64
$34.89

Technical Indicators

Market Signals
Indicator
LYNX
DMRA
Relative Strength Index (RSI) 30.51 36.78
Support Level N/A $18.73
Resistance Level $13.74 $26.76
Average True Range (ATR) 0.65 1.28
MACD -0.12 0.23
Stochastic Oscillator 1.75 52.25

Price Performance

Historical Comparison
LYNX
DMRA

About LYNX Lyntris Inc. Common Stock

Lyntris Inc is a defense technology company that develops connectivity solutions for military applications. Its products consist of interconnected subsystems designed to support defense and military customers in detecting threats, making decisions, and responding to operational requirements across multi-domain environments. The company serves U.S. and allied nation military customers. Its solutions are deployed across three core missions: Maritime Domain Awareness; Air & Missile Defense; and Space ISR & Resilient Communications. Maximum revenue is derived from the Maritime Domain Awareness business, which includes solutions focused on maritime monitoring, tracking and analysis that support government and defense customers in maintaining situational awareness across maritime environments.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: